Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy

Background Diabetes mellitus (DM) is a metabolic disease with a large incidence in the world and constitutes a global health problem. By 2030 it is estimated that there will be around 439 million people suffering from DM. Diabetes mellitus is a metabolic disease caused by a lack or absence of the ho...

Full description

Bibliographic Details
Main Authors: Alvina Lesmana, Pusparini Pusparini, Meiyanti Meiyanti, Lie T Merijanti
Format: Article
Language:English
Published: Faculty of Medicine Trisakti University 2020-03-01
Series:Universa Medicina
Subjects:
Online Access:https://univmed.org/ejurnal/index.php/medicina/article/view/881
_version_ 1831543335622279168
author Alvina Lesmana
Pusparini Pusparini
Meiyanti Meiyanti
Lie T Merijanti
author_facet Alvina Lesmana
Pusparini Pusparini
Meiyanti Meiyanti
Lie T Merijanti
author_sort Alvina Lesmana
collection DOAJ
description Background Diabetes mellitus (DM) is a metabolic disease with a large incidence in the world and constitutes a global health problem. By 2030 it is estimated that there will be around 439 million people suffering from DM. Diabetes mellitus is a metabolic disease caused by a lack or absence of the hormone insulin. In type 2 DM pharmacotherapy can be given one of which is insulin. To monitor therapy, random blood glucose, glycated hemoglobin (HbA1c) and glycated albumin (GA) levels can be examined. The objective of this study was to determine the relationship of glycated albumin and glycated hemoglobin (HbA1c) with random blood glucose in insulin-treated diabetics. Methods A cross-sectional study was conducted involving 92 type 2 diabetic patients treated with insulin. The study used a questionnaire and blood samples. We measured the GA , HbA1C and random blood glucose levels. A multiple linear regression was used to analyze the data. Results Mean HbA1c was 9.21 ± 2.15%, mean glycated albumin was 24.4 ± 8.65%, and mean blood glucose was 229.47 ± 98.7 mg/dL. Multiple linear regression tests showed that HbA1c (B= 5,544; â=0.121; p=0.420) and GA (B=5.899; â=0.517; p=0.001) was signigicantly corelated with random blood gucose, respectively, indicating that glycated albumin is significantly related to and has the greatest influence on glucose level. Conclusion Glycated albumin is correlated with and has greater influence on glucose level than does HbA1c. Glycated albumin could be a better marker for glycemic control than glycated hemoglobin in diabetic patients treated with insulin.
first_indexed 2024-12-17T00:49:28Z
format Article
id doaj.art-c97c6c0ab2ee41a19e9a0218e025f130
institution Directory Open Access Journal
issn 1907-3062
2407-2230
language English
last_indexed 2024-12-17T00:49:28Z
publishDate 2020-03-01
publisher Faculty of Medicine Trisakti University
record_format Article
series Universa Medicina
spelling doaj.art-c97c6c0ab2ee41a19e9a0218e025f1302022-12-21T22:09:48ZengFaculty of Medicine Trisakti UniversityUniversa Medicina1907-30622407-22302020-03-0139110.18051/UnivMed.2020.v39.27-33397Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapyAlvina Lesmana0Pusparini Pusparini1Meiyanti Meiyanti2Lie T Merijanti3Department of Clinical Pathology of Medicine Trisakti UniversityDepartment of Clinical Pathology of Medicine Trisakti UniversityDepartment of Pharmacology and Pharmacy Faculty of Medicine Trisakti UniversityDepartment of Occupational Medicine Faculty of Medicine Trisakti UniversityBackground Diabetes mellitus (DM) is a metabolic disease with a large incidence in the world and constitutes a global health problem. By 2030 it is estimated that there will be around 439 million people suffering from DM. Diabetes mellitus is a metabolic disease caused by a lack or absence of the hormone insulin. In type 2 DM pharmacotherapy can be given one of which is insulin. To monitor therapy, random blood glucose, glycated hemoglobin (HbA1c) and glycated albumin (GA) levels can be examined. The objective of this study was to determine the relationship of glycated albumin and glycated hemoglobin (HbA1c) with random blood glucose in insulin-treated diabetics. Methods A cross-sectional study was conducted involving 92 type 2 diabetic patients treated with insulin. The study used a questionnaire and blood samples. We measured the GA , HbA1C and random blood glucose levels. A multiple linear regression was used to analyze the data. Results Mean HbA1c was 9.21 ± 2.15%, mean glycated albumin was 24.4 ± 8.65%, and mean blood glucose was 229.47 ± 98.7 mg/dL. Multiple linear regression tests showed that HbA1c (B= 5,544; â=0.121; p=0.420) and GA (B=5.899; â=0.517; p=0.001) was signigicantly corelated with random blood gucose, respectively, indicating that glycated albumin is significantly related to and has the greatest influence on glucose level. Conclusion Glycated albumin is correlated with and has greater influence on glucose level than does HbA1c. Glycated albumin could be a better marker for glycemic control than glycated hemoglobin in diabetic patients treated with insulin.https://univmed.org/ejurnal/index.php/medicina/article/view/881HbA1cglycated albuminblood glucosediabetic type 2 patients
spellingShingle Alvina Lesmana
Pusparini Pusparini
Meiyanti Meiyanti
Lie T Merijanti
Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy
Universa Medicina
HbA1c
glycated albumin
blood glucose
diabetic type 2 patients
title Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy
title_full Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy
title_fullStr Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy
title_full_unstemmed Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy
title_short Glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy
title_sort glycated albumin is a better indicator for glucose levels than glycated hemoglobin in patients with diabetes mellitus on insulin therapy
topic HbA1c
glycated albumin
blood glucose
diabetic type 2 patients
url https://univmed.org/ejurnal/index.php/medicina/article/view/881
work_keys_str_mv AT alvinalesmana glycatedalbuminisabetterindicatorforglucoselevelsthanglycatedhemoglobininpatientswithdiabetesmellitusoninsulintherapy
AT pusparinipusparini glycatedalbuminisabetterindicatorforglucoselevelsthanglycatedhemoglobininpatientswithdiabetesmellitusoninsulintherapy
AT meiyantimeiyanti glycatedalbuminisabetterindicatorforglucoselevelsthanglycatedhemoglobininpatientswithdiabetesmellitusoninsulintherapy
AT lietmerijanti glycatedalbuminisabetterindicatorforglucoselevelsthanglycatedhemoglobininpatientswithdiabetesmellitusoninsulintherapy